The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Current understanding of Alzheimer’s disease diagnosis and treatment
Open accessAbstract
Alzheimer’s disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. This neurodegenerative disease process is characterized classically by two hallmark pathologies: β-amyloid plaque deposition and neurofibrillary tangles of hyperphosphorylated tau. Diagnosis is based upon clinical presentation fulfilling several criteria as well as fluid and imaging biomarkers. Treatment is currently targeted toward symptomatic therapy, although trials are underway that aim to reduce the production and overall burden of pathology within the brain. Here, we discuss recent advances in our understanding of the clinical evaluation and treatment of Alzheimer’s disease, with updates regarding clinical trials still in progress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, both PET imaging and CSF analysis exhibit similar accuracy, and suggest that the optimum test for the diagnosis will depend upon patient/provider preference, cost and availability of facilities [37].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [37]
In the citing paper
“Current therapeutics to ameliorate and control the cognitive and behavioral symptoms by targeting the NMDA receptor prevent Ca2+ induced excitotoxicity [2, 9–11], and memantine was approved for this purpose in 2003.”
From Current therapeutics for Alzheimer’s disease and clinical trials (2024) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzen, E. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0655 · Cited by 8,467
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796
Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,643
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Mechanism of tripeptide trimming by γ-secretase
Bhattarai, A., Devkota, S., Do, H. N., Wang, J., Bhattarai, S., Wolfe, M. S., & Miao, Y. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2021.11.2298
Schleicher, E. M. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8990
Piovesan, E. C., de Freitas, B. Z., Lemanski, F. C. B., Penno, J. V. E., Bigolin, P. H. G., Hammacher, G. K., Ceolin, A. A., & Carazzo, C. A. (2022) · Editora Científica Digital eBooks · doi:10.37885/220107432
THE ROLE OF METABOLIC SYNDROME IN THE ALZHEIMER’S DISEASE
Santos, A. E. M. D. S., Senhorinha, G. M., Teodoro, D. T., Firmino, F. F., Braudes, I. C. S., & de Lucena, L. S. (2021) · Health and Society · doi:10.51249/hes01.03.2021.346
Meta-Analysis of Natural vs Pharmaceutical Interventions for Alzheimer's Disease
Vrublevskaya, T. (2021) · San José State University ScholarWorks (San Jose State University) · doi:10.31979/etd.b494-dcd5
Genetic Dependency of Alzheimer’s Disease-Associated Genes across Cells and Tissue TypesPreprint
Jaladanki, S. K., Elmas, A., Santos-Malave, G., & Huang, K. (2021) · Research Square · doi:10.21203/rs.3.rs-153131/v1
Korábečný, J., & Soukup, O. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-1797-1
Ananthula, S., Appavu, R., & Kethar, J. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v10i4.2103
Applications of Nanotechnology in Alzheimer’s Disease
Chountoulesi, M., Naziris, N., Gioran, A., Papagiannopoulos, A., Steele, B. R., Micha‐Screttas, M., Stavrinides, S. G., Hanias, M. P., Chondrogianni, N., Pispas, S., et al. (2022) · Springer eBooks · doi:10.1007/978-3-319-75479-6_16-1
Exostose Idiopática: raridade no seio maxilar.
Faria, V. D. A. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220505865
Alves, M. P., & Martins-Ferreira, J. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220505859
ANÁLISE SOCIODEMOGRÁFICO DOS ACIDENTES OFÍDICOS NO ESTADO DO CEARÁ NO ANO DE 2017
Souza, G. D. A., Souza, M. D. A., Barreto, L. P., & Monte, M. B. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220505892
(2022) · Editora Conhecimento Livre eBooks · doi:10.37423/2022.edcl497
Aprendizados na Unidade de Saúde da Família - Relato de Experiência
Guedes, B. D. S. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220505845
Lage, I. A., Zimmerer, Á. G., Pena, L. B., & Lemos, D. M. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220505784
COMPORTAMENTO ACADÊMICO DE RISCO PARA O DESENVOLVIMENTO DE CÂNCER COLORRETAL
Freitas, K. A., Silva, M. G., Ferreira, A. G. D. J., Amaral, L. L., & Barbosa, H. A. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220505787
Braz, H. L., da Cunha, A. H. V. T., Simões, P. W. T. D. A., & Prado, C. D. E. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220505777
A neuroimagem no diagnóstico da doença de Alzheimer: uma revisão de literatura
Viana, G. M. C., Fernandes, B. B., Amoy, M. F. L. F., & Reis, B. C. C. (2022) · Revista Eletrônica Acervo Médico · doi:10.25248/reamed.e10050.2022
Links Between Supplements and Alzheimer’s Disease
Aguilar, J., Fraire, D., Garza, A. J. D. L., Martinez, B., Sendejo, N., Solis, J. R., & Suarez, S. (2022) · DHR Proceedings · doi:10.47488/dhrp.v2is2.45
A Bayesian Latent Scale Model for Multivariate Longitudinal Data
Pandya, K. (2022) · PDXScholar (Portland State University) · doi:10.15760/etd.7930
Perspectives of Stem Cell Therapy: A Promising Therapeutic for Cancer Model and Alzheimer’s Disease
Jeyachandran, S., Ganesan, G., Sangeetha, R., Paramasivan, V., Subbaraj, G. K., & Kulanthaivel, L. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_32-1
Acupuncture and Alzheimer’s Disease
Xu, Y., Wen, G., Asakawa, T., & Xia, Y. (2022) · Springer eBooks · doi:10.1007/978-3-030-96221-0_23
Călınescu, A. (2022) · New Literaria · doi:10.48189/nl.2022.v03i2.018
Progress in the Detection of Cerebrospinal Fluid by Raman Spectroscopy
Zeng, T., Song, Y., Bian, H., Lin, T., Liu, Y., Deng, S., Liao, J., Mao, Z., & Chen, S. (2022) · Current Nanoscience · doi:10.2174/1573413718666220803141856
Zhao, R., Wang, P., Zhang, F., Hu, P., Wen, J., Li, H., & Biswal, B. B. (2022) · Research Square · doi:10.21203/rs.3.rs-2012793/v1
Jomehpour, D., Sheikhlary, S., Heydari, E., & Ara, M. H. M. (2022) · Research Square · doi:10.21203/rs.3.rs-2090375/v1
Endothelin Receptors in Cerebrovascular Diseases
Briyal, S., Ranjan, A. K., & Gulati, A. (2022) · doi:10.1002/9781119564782.ch16
Noel, R. L., Batts, A. J., & Konofagou, E. E. (2022) · IEEE International Ultrasonics Symposium · doi:10.1109/ius54386.2022.9957937
Gene Regulatory Network Reconstruction Using Single-Cell RNA-Sequencing
Koumadorakis, D. E., Dimitrakopoulos, G. Ν., Krokidis, M. G., & Vrahatis, A. G. (2022) · Springer eBooks · doi:10.1007/978-3-319-75479-6_18-1
The consequences of depression in Alzheimer's: A Literature Review
Santos, M. P., Mansur, M. P. C. R., Beraldo, D. F. G. D. C. G. H. V. V. C. A. L. B. R. C. J. M. F. C. S. L. C. C. S., Araújo, R. A., Vieira, G. H., & Loyola, A. B. A. T. (2022) · International Journal of Health Science · doi:10.22533/at.ed.1592772202123
Possible cause of Alzheimer's disease related to HSV-1 infection and signal transmission
Shen, Z. (2022) · International Symposium on Artificial Intelligence for Medicine Sciences (ISAIMS) · doi:10.1145/3570773.3570887
A Review on the Techniques for Early Diagnosis of Alzheimer’s Disease
Shahzadi, M., Saeed, B., Khan, M. A., Rashid, A., Bilal, M., Imtiaz, R., & Faridi, T. A. (2022) · Lahore Garrison University Journal of Life Sciences · doi:10.54692/lgujls.2022.0603228
A Potential New Alzheimer’s Treatment That May Function by Modulating the Gut Microbiota
Wakelin, S. (2022) · touchREVIEWS in Neurology · doi:10.17925/usn.2022.18.suppl.1.4
The Potential Role of Inflammation in Alzheimer’s Disease
Cummings, J. L. (2022) · touchREVIEWS in Neurology · doi:10.17925/usn.2022.18.suppl.1.2
Unveiling the Role of MicroRNA-132 on Alzheimer's Disease Brain Cells
Kim, H., & Kim, D. (2023) · International journal of high school research · doi:10.36838/v5i1.8
Factors and Concequences of Dementia Among Adults of Old Age in Karachi
Shahid, F., Tahir, S., Hassan, A., Sana, L., Arshud, M., Yasin, S., Siddique, S., Ullah, A., & Nadeem, H. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs20221612828
Disruptions of Circadian Rhythms and Sleep/Wake Cycles in Neurologic Disorders
Walker, W. H., Liu, J. A., & Nelson, R. J. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-22468-3_22
A Preliminary Study on the Mechanism of Alcohol Abuse in Alzheimer’s Disease
徐, 加. (2023) · Open Journal of Natural Science · doi:10.12677/ojns.2023.112017
Alzheimer’s Disease and Stem Cell Therapy
Liao, J. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5722
Wszystko na swoim miejscu – rola receptorów VPS10P w komórkowej segregacji białek
Kamińska, P., Piątek, S., Bieniek, M., & Malik, A. R. (2023) · Postępy Biochemii · doi:10.18388/pb.2021_473 · Cited by 1
Babylon, L., Meißner, J., & Eckert, G. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.24.538048
Zhang, M., Ge, M., Li, Q., Li, H., Jiao, L., & Wu, W. (2023) · Preprints.org · doi:10.20944/preprints202306.0919.v1
Mechanism and treatment of cell death in Alzheimer's disease
Zhu, Z. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v54i.9774
A Brief Review of Image Classification Techniques for Alzheimer’s Disease Detection
Chouhan, M., & Pareek, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-4056-1_23
Özkoç, M., Can, B., İlhan, A. O., Söğüt, İ., Ataızı, Z. S., Kandemir, T., Dönmez, D. B., & Kanbak, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3346277/v1
Lloyd, R. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-39554-3_12
Carroll, P., & Kakarla, S. (2020) · Journal of Emerging Investigators · doi:10.59720/20-099
Varnagar, C. R., & Shah, H. B. (2023) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_53_23
EEG Source Localization Based Regional-Marker for Impairment Prediction in Alzheimer's Disease
Ranjan, S., & Kumar, L. (2023) · International symposium on image and signal processing and analysis/ISPA ... · doi:10.1109/ispa58351.2023.10279280
Modern approaches to pharmacotherapy of Alzheimer's disease
Davydov, G. S., & Геннадьевна, Ф. С. (2023) · Scientific Bulletin of the Omsk State Medical University · doi:10.61634/2782-3024-2023-9-31-40
Shark fish oil prevents scopolamine-induced memory impairment in an experimental model
Naeem, S., Ali, L., Jaffar, N., Khan, S. S., Shafiq, Y., Suri, S., & Tahir, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01320-5
Suzan, A. A., & Barut, B. Ö. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2293109
CUIDADOS PALIATIVOS NA DOENÇA DE ALZHEIMER: RELATO DE EXPERIÊNCIA
Moura, C. A. D., & Lopes, G. D. S. (2023) · Revista Contemporânea · doi:10.56083/rcv3n12-151
Mechanism and treatment of Alzheimer’s disease
Gu, Z., Tie, Z., & Ruan, H. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/21/20230865
Medicina, F. D. I. C. E. (2024) · Even3 Publicações eBooks · doi:10.29327/5342373
Moncayo-Gaete, J., Mendoza-Tirado, E., Duque, L., Guapisaca, F., Narváez, M. R. A., Chiriboga-Lozada, S., Romero-Cortez, F., & Proaño, S. P. R. (2024) · Revista de la Facultad de Ciencias Médicas (Quito) · doi:10.29166/rfcmq.v49i1.5824
An overview on Alzheimer’s disease, diagnosis and treatment approach
Nivetha, S. R., Shivani, K., Vigneshwaran, R., Prasanna, G. L., & Veeramani, M. (2023) · International Journal of Allied Medical Sciences and Clinical Research · doi:10.61096/ijamscr.v11.iss4.2023.379-391 · Cited by 1
Diagnostic indexes and pharmacological treatment of Alzheimer’s disease
Zhu, Y. (2024) · MedScien · doi:10.61173/g4h1wh79
Chakraborty, R., Ghosh, A., Mandal, J. K., Choudhury, T., & Chatterjee, P. (2024) · Wiley eBooks · doi:10.1002/9781394277599.ch8
Methylene blue treatment on Alzheimer and inflammatory bowel disease
Öğünç, B., Ramoğlu, N., & Sakin, I. (2021) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2020.25053
Transcranial Direct Current Stimulation in neurological disorders
Knotková, H., VanZyl, J., & Portenoy, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18496-3.00008-2
A Comprehensive Review on the Newer Therapeutic Approaches in Treating Alzheimer’s Disease
Prakash, R., Jayaraman, R., Palei, N. N., Prakash, D. J., & Ronald, D. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_40-1
Potential Effects of Antiaging Compounds: Implications on Brain Aging
Abinaya, G. P., Iyshwarya, B. K., & Veerabathiran, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-7269-2_9
A Mini Review on The Roles of Beta-Amyloid and Tau Proteins in Huntington’s Disease
Kahrizsangi, S. S., Shaibie, N. A., Ling, A. P. K., Chye, S. M., Ng, K. Y., & Koh, R. Y. (2024) · ASM Science Journal · doi:10.32802/asmscj.2023.1449
Singh, S. P., Dwivedi, D., Ahsan, R., Srivastava, A., & Shukla, A. K. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010004
Haghdoost-Yazdi, H., Nigjeh, S., Hosseini, S. A. H., Sharifi, S., Kaveh, F., & Piri, H. (2024) · Majallah-i dānishgāh-i ̒ulum-i pizishkī-i Kirmān. · doi:10.34172/jkmu.2024.18
A Comprehensive Review on the Newer Therapeutic Approaches in Treating Alzheimer’s Disease
Prakash, R., Jayaraman, R., Palei, N. N., Prakash, D. J., & Ronald, D. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_40
New drugs for Alzheimer’s disease: Aducanumab or Donanemab?
Joodaki, M., Shirazi, M. M., & Hosseini, N. (2024) · Physiology and Pharmacology · doi:10.61186/phypha.28.3.219
Nakamine, A. A., da Costa, L. E. S., & Rocha, W. S. D. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n11-140
Amyloid, Tau, and ApoE: Revisiting Hypotheses of Alzheimer's Disease
Yao, B., Kuang, M., Jiang, D. F., & Xu, C. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19396
Rabbani, M., Abaei, M. K., & Hosseini-Sharifabad, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5092353
Shin, H., Seong, W., Woo, Y., Kim, J., Park, K.-R., & Lee, D. H. (2025) · JMIR Research Protocols · doi:10.2196/66838
Prevention and Reduction of Risk of AD: Lifestyle Changes, Dietary Changes, Supplements, and More
Mishra, A. S., Vasanthan, M., Swain, S. S., & Karri, V. V. S. R. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_19
Multilayer Network Analysis of Brain Signals for Detecting Alzheimer’s Disease
Nguyen, S. M., Basiri, M. A., & Khanmohammadi, S. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-82768-6_13
Inhibitory Effects of Alkaloids Against Enzymes Linked to Neurodegenerative Diseases
Orhan, İ. E., & Deniz, F. S. S. (2025) · Springer eBooks · doi:10.1007/978-3-642-36202-6_23-1
Quercetin as a Complementary Therapy in Substance Use Disorder: A Narrative Review
Soltaninejad, M., Ilaghi, M., Amleshi, R. S., & Shabani, M. (2025) · Majallah-i dānishgāh-i ̒ulum-i pizishkī-i Kirmān. · doi:10.34172/jkmu.3816
Targeting amyloidogenic proteins through cyclic peptides – A medicinal chemistry perspective
Zargaham, M. K., Ibrahim, A., Ahmed, M., Babar, M. M., & Rajadas, J. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118165 · Cited by 1
Hu, M., Esmaeeli, S., Stolzenburg, L. R., Milkovich, B., Jouni, M., Nyamugenda, E., Hammond, R. K., Reinhardt, P., Bahnassawy, L., Gasparini, L., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.1101/2025.03.31.646439 · Cited by 2
Dementia Care: A Test Case for the Humanity of AI in Health and Nursing Care
Boddington, P. (2025) · SpringerBriefs in philosophy · doi:10.1007/978-3-031-85478-1_11
Real-Time Imaging of Single Neuronal Cell Apoptosis (DARC)
Yap, T. E., Kelada, M., Sher, A., Szymanska, M., Patel, R. P., & Cordeiro, M. F. (2025) · Springer eBooks · doi:10.1007/978-3-031-72156-4_7
OuYang, C., Shi, H., & Lin, Z. (2025) · Neurological Research · doi:10.1080/01616412.2025.2499890
He, Y., Li, J., Zhao, K., Shi, L., Zhou, H., Li, Y., Zhao, Q., Ya, J., & Wu, C. (2025) · Research Square · doi:10.21203/rs.3.rs-6395732/v1
Shihab, Z., & Abbas, H. H. (2021) · Kerbala Journal for Engineering Sciences · doi:10.63463/kjes1024
New Possibilities for Evaluating Markers of Alzheimer's Disease in Blood Serum
Vorobyev, S. V., Plekhanov, A. Y., Ternovykh, I. К., Усиков, А. С., Lebedev, A. А., Smirnov, A. N., Shmidt, N. M., Dunaevskiy, M. S., & Павлович, Л. С. (2025) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2025-70-1-2-20-28
Yang, Y., Wang, C., Kong, J., Zhang, J., & Wong, M. S. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165383
Chen, F., Deng, H., Zhang, Q., Liu, Y., Zhang, Y., Zhang, Y., Li, D., & Meng, X. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352510
龚, 浩. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1571962
Tao, Y., Wan, G., & Zhou, X. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01782-2
Yung, M., & Zhu, W. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.24.666703
The Effect of Early Diagnosis of Alzheimer’s Disease: A Short Systematic Review
Kazemi, K. (2025) · Premier Journal of Neuroscience · doi:10.70389/pjn.100010
Li, J., Lin, Z., Niu, Y., Chang, W., Song, S., Yang, G., Liu, F., Dai, J., & Hao, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251367046
Wang, G., Li, Y., Zhou, Z., An, S., Cao, X., Jin, Y., Sun, Z., Chen, G., Zhang, M., Li, Z., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1626922
Precise ligand-selective mechanism at the fab domain of a tau-recognizing antibody
Tsuchida, T., Tsuchiya, T., Minoura, K., In, Y., Miyamoto, K., Taniguchi, T., Ishida, T., & Tomoo, K. (2025) · Journal of Structural Biology · doi:10.1016/j.jsb.2025.108250
The Impact of Traditional Chinese Medicine in Quality of Life of Elderly People with Alzheimer
Figueira, A., Montês, Â., Oliveira, C., & Guarda, T. (2025) · Springer proceedings in business and economics · doi:10.1007/978-3-031-94487-1_29
An overview of intranasal drug delivery systems for Alzheimer’s disease
Unnissa, Z., Unissa, M., Hussain, M. M., & Ali, S. S. (2025) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20253380
Metadata
- Authors
- Weller, J., & Budson, A.
- Affiliations
- Boston University (US)
- Corresponding author
- Weller, Jason
- Venue
- F1000Research
- Publisher
- F1000 Research Ltd
- Published
- 2018-07-31
- Volume
- 7
- Pages
- 1161
- ISSN
- 2046-1402 (ISSN-L)
- PMC
- PMC6073093
- OpenAlex
- W2885706121
- Cited by
- 1,083
- References
- 53
- Citations by year
- 2026: 67 · 2025: 155 · 2024: 147 · 2023: 176 · 2022: 221 · 2021: 194 · 2020: 92 · 2019: 29 · 2018: 2
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- F1000Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Aging (P30AG013846)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- Alzheimer's disease, dementia, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, biomarkers, diagnosis, symptomatic treatment, disease-modifying therapy, clinical trials, neurodegeneration
- MeSH terms
- Alzheimer Disease, Humans, Nerve Net, Amyloid beta-Peptides, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
